Golden
Arpeggio Biosciences

Arpeggio Biosciences

A a biotechnology company developing a drug-screening platform for the acceleration of drug discovery by combining custom laboratory assay and proprietary machine learning algorithms.

All edits by  Will Suter 

Edits on 13 Aug 2019
Will Suter
Will Suter approved a suggestion from Golden's AI on 13 Aug 2019 5:54 pm
Edits made to:
Article (+17/-17 characters)

Article

Arpeggio Biosciences is a biotechnology company headquartered in Boulder, ColoradoBoulder, Colorado that was founded in 2017 by Robin Dowell and Joey Azofeifa. Arpeggio Biosciences headquarters is located in the BioFrontiers Institute in the University of Boulder Colorado. The company is developing a drug-screening platform for the acceleration of drug discovery by combining custom laboratory assay and proprietary machine learning algorithms.

Will Suter
Will Suter approved a suggestion from Golden's AI on 13 Aug 2019 5:48 pm
Edits made to:
Article (+14/-14 characters)

Article

Arpeggio Biosciences is a biotechnology company headquartered in Boulder, Colorado that was founded in 2017 by Robin Dowell and Joey Azofeifa. Arpeggio Biosciences headquarters is located in the BioFrontiers Institute in the University of Boulder Colorado. The company is developing a drug-screening platform for the acceleration of drug discoverydrug discovery by combining custom laboratory assay and proprietary machine learning algorithms.

No more activity to show.